Article perview reprinted from IN VIVO - July/August 2009
Device deals--albeit fewer--are still getting done in the current environment, and many investors remain bullish on devices. A panel of venture investors--both VC and corporate--who are still active dealmakers, discuss what they want to see today in start-up companies, and whether the device investment model has changed both for now and the future. Read more...
Continue reading "Device Investing in Tough Times: The Venture View" »
Article preview reprinted from Start-Up - July 2009
invendo medical has crystallized its mission around solving not just the single issue of sedationless colonoscopy, which is regarded by some as the solution to getting more patients into the endoscopy suite for colorectal cancer screening, but all three of what the company characterizes as the major drawbacks of colonoscopy: 1) patient discomfort (triggering the costs and complications of sedation); 2) the ease-of-use issue, or rather, the challenging learning curve of conventional endoscopes; and 3) the reusability that leads to cumbersome cleaning routines and residual infection risk. Invendo has developed a non-push scope that drives itself under the operator's control. Read more...
Continue reading "invendo medical GMBH" »
Article perview reprinted from "The Gray Sheet" - August 17, 2009
The medical device industry is asking the Supreme Court to overturn a Federal Circuit court decision that could exclude some diagnostics from patent eligibility.
Continue reading "Supreme Court Case Could Narrow Patent Eligibility For Diagnostics " »
Article perview reprinted from "The Gray Sheet" - August 17, 2009
A friendly reminder to pre-amendments device makers: failing to submit the safety and effectiveness information FDA ordered on 25 device types this April could result in seizure, injunction or even criminal prosecution. Read More...
Continue reading "FDA Begins Review Of Pre-amendments Device Data Submissions " »
Article perview reprinted from "The Gray Sheet" - August 17, 2009
Recent changes will speed FDA's process for barring non-compliant clinical trial investigators from future product research, agency staffers say.
Continue reading "FDA Will Move Faster To Ban Bad Actors From Clinical Trials " »
Deal summary reprinted from Strategic Transactions - July 2009
BeneChill (therapeutic hypothermia-inducing device) has raised $13.5mm through its Series C venture round. New backer HealthCap led the financing and contributes a board member. Returning shareholders MedVenture Associates, NGN Capital, and the Solon Foundation also participated. Read more...
Continue reading "BeneChill raises $13.5mm through Series C round" »
Early-Bird Discount For PharmAsia Summit Expires Aug. 31
As pharma looks to broaden its capabilities beyond its four walls and spread the risk and rewards of drug development, companies are looking east to the multi-billion dollar Asian market, especially emerging markets like China and India. Read more...
Continue reading "Hear China & India Case Studies From Industry Leaders" »
Article preview reprinted from Start-Up - July 2009
The field of gastroenterology is tantalizing for device manufacturers because it offers one of the rare screening paradigms in medicine, and therefore, enormous markets. In the US, it's recommended that everyone over the age of 50 be screened for colorectal cancer by a colonoscopy procedure. However, compliance with colorectal screening recommendations is low, less than 50% for colonoscopy, the gold standard for detecting precancerous polyps. GI endoscopy is unusual among screening paradigms in its degree of invasiveness and cost, and that limits access to screening. Medtech start-ups hope to improve upon this state of affairs by offering new technologies to improve the ease, decrease the discomfort, and increase the efficiency of endoscopic procedures. Read more...
Continue reading "Scoping out Gastroenterology Start-Ups " »